nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ORM1—Erlotinib—pancreatic cancer	0.148	0.209	CbGbCtD
Pethidine—CYP2B6—Tamoxifen—pancreatic cancer	0.0747	0.105	CbGbCtD
Pethidine—ALB—Erlotinib—pancreatic cancer	0.0623	0.0879	CbGbCtD
Pethidine—CYP2B6—Irinotecan—pancreatic cancer	0.0574	0.0809	CbGbCtD
Pethidine—ALB—Irinotecan—pancreatic cancer	0.0563	0.0793	CbGbCtD
Pethidine—ALB—Fluorouracil—pancreatic cancer	0.054	0.0761	CbGbCtD
Pethidine—CYP2C19—Tamoxifen—pancreatic cancer	0.0475	0.067	CbGbCtD
Pethidine—CYP2D6—Tamoxifen—pancreatic cancer	0.0361	0.0509	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—pancreatic cancer	0.0314	0.0442	CbGbCtD
Pethidine—CYP2D6—Erlotinib—pancreatic cancer	0.0307	0.0433	CbGbCtD
Pethidine—CYP3A4—Tamoxifen—pancreatic cancer	0.023	0.0324	CbGbCtD
Pethidine—CYP3A4—Erlotinib—pancreatic cancer	0.0195	0.0275	CbGbCtD
Pethidine—CYP3A4—Irinotecan—pancreatic cancer	0.0176	0.0249	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—pancreatic cancer	0.0151	0.0214	CbGbCtD
Pethidine—CYP3A4—Docetaxel—pancreatic cancer	0.0129	0.0182	CbGbCtD
Pethidine—CYP3A4—Sunitinib—pancreatic cancer	0.0129	0.0181	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—pancreatic cancer	0.00963	0.0136	CbGbCtD
Pethidine—Anxiety—Tamoxifen—pancreatic cancer	0.000748	0.00452	CcSEcCtD
Pethidine—Sweating—Gemcitabine—pancreatic cancer	0.000744	0.0045	CcSEcCtD
Pethidine—Anxiety—Erlotinib—pancreatic cancer	0.000741	0.00448	CcSEcCtD
Pethidine—Dry mouth—Tamoxifen—pancreatic cancer	0.000735	0.00444	CcSEcCtD
Pethidine—Bradycardia—Irinotecan—pancreatic cancer	0.000728	0.0044	CcSEcCtD
Pethidine—Muscle spasms—Sunitinib—pancreatic cancer	0.000726	0.00439	CcSEcCtD
Pethidine—Oedema—Tamoxifen—pancreatic cancer	0.00072	0.00435	CcSEcCtD
Pethidine—Delirium—Doxorubicin—pancreatic cancer	0.000714	0.00432	CcSEcCtD
Pethidine—Oedema—Erlotinib—pancreatic cancer	0.000712	0.00431	CcSEcCtD
Pethidine—Dyskinesia—Epirubicin—pancreatic cancer	0.000706	0.00427	CcSEcCtD
Pethidine—Shock—Erlotinib—pancreatic cancer	0.000701	0.00424	CcSEcCtD
Pethidine—Vasodilation procedure—Doxorubicin—pancreatic cancer	0.000699	0.00422	CcSEcCtD
Pethidine—Vasodilation—Doxorubicin—pancreatic cancer	0.000699	0.00422	CcSEcCtD
Pethidine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000696	0.00421	CcSEcCtD
Pethidine—Visual impairment—Irinotecan—pancreatic cancer	0.000689	0.00416	CcSEcCtD
Pethidine—Anorexia—Tamoxifen—pancreatic cancer	0.000686	0.00415	CcSEcCtD
Pethidine—Anorexia—Erlotinib—pancreatic cancer	0.000679	0.0041	CcSEcCtD
Pethidine—Coordination abnormal—Epirubicin—pancreatic cancer	0.000676	0.00409	CcSEcCtD
Pethidine—Flushing—Irinotecan—pancreatic cancer	0.000664	0.00401	CcSEcCtD
Pethidine—Convulsion—Sunitinib—pancreatic cancer	0.000655	0.00396	CcSEcCtD
Pethidine—Dyskinesia—Doxorubicin—pancreatic cancer	0.000654	0.00395	CcSEcCtD
Pethidine—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.000653	0.00394	CcSEcCtD
Pethidine—Hypertension—Sunitinib—pancreatic cancer	0.000652	0.00394	CcSEcCtD
Pethidine—Insomnia—Tamoxifen—pancreatic cancer	0.000651	0.00394	CcSEcCtD
Pethidine—Insomnia—Erlotinib—pancreatic cancer	0.000644	0.00389	CcSEcCtD
Pethidine—Dry mouth—Sunitinib—pancreatic cancer	0.000629	0.0038	CcSEcCtD
Pethidine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000626	0.00378	CcSEcCtD
Pethidine—Coordination abnormal—Doxorubicin—pancreatic cancer	0.000626	0.00378	CcSEcCtD
Pethidine—Decreased appetite—Erlotinib—pancreatic cancer	0.000619	0.00374	CcSEcCtD
Pethidine—Oedema—Sunitinib—pancreatic cancer	0.000617	0.00373	CcSEcCtD
Pethidine—Constipation—Tamoxifen—pancreatic cancer	0.000616	0.00372	CcSEcCtD
Pethidine—Constipation—Erlotinib—pancreatic cancer	0.000609	0.00368	CcSEcCtD
Pethidine—Shock—Sunitinib—pancreatic cancer	0.000607	0.00367	CcSEcCtD
Pethidine—Coma—Epirubicin—pancreatic cancer	0.000607	0.00367	CcSEcCtD
Pethidine—Erythema—Gemcitabine—pancreatic cancer	0.000606	0.00366	CcSEcCtD
Pethidine—Muscle spasms—Irinotecan—pancreatic cancer	0.000598	0.00362	CcSEcCtD
Pethidine—Erythema—Fluorouracil—pancreatic cancer	0.000596	0.0036	CcSEcCtD
Pethidine—Anorexia—Sunitinib—pancreatic cancer	0.000588	0.00355	CcSEcCtD
Pethidine—Urticaria—Tamoxifen—pancreatic cancer	0.000572	0.00346	CcSEcCtD
Pethidine—Coma—Doxorubicin—pancreatic cancer	0.000561	0.00339	CcSEcCtD
Pethidine—Phlebitis—Epirubicin—pancreatic cancer	0.000559	0.00338	CcSEcCtD
Pethidine—Vertigo—Irinotecan—pancreatic cancer	0.000559	0.00338	CcSEcCtD
Pethidine—Syncope—Irinotecan—pancreatic cancer	0.000558	0.00337	CcSEcCtD
Pethidine—Insomnia—Sunitinib—pancreatic cancer	0.000558	0.00337	CcSEcCtD
Pethidine—Loss of consciousness—Irinotecan—pancreatic cancer	0.000547	0.00331	CcSEcCtD
Pethidine—Hypertension—Irinotecan—pancreatic cancer	0.000537	0.00325	CcSEcCtD
Pethidine—Decreased appetite—Sunitinib—pancreatic cancer	0.000536	0.00324	CcSEcCtD
Pethidine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00053	0.00321	CcSEcCtD
Pethidine—Constipation—Sunitinib—pancreatic cancer	0.000527	0.00319	CcSEcCtD
Pethidine—Hypertension—Gemcitabine—pancreatic cancer	0.000523	0.00316	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—pancreatic cancer	0.000518	0.00313	CcSEcCtD
Pethidine—Asthenia—Tamoxifen—pancreatic cancer	0.000517	0.00312	CcSEcCtD
Pethidine—Convulsion—Fluorouracil—pancreatic cancer	0.000516	0.00312	CcSEcCtD
Pethidine—Confusional state—Irinotecan—pancreatic cancer	0.000512	0.0031	CcSEcCtD
Pethidine—Asthenia—Erlotinib—pancreatic cancer	0.000511	0.00309	CcSEcCtD
Pethidine—Pruritus—Tamoxifen—pancreatic cancer	0.000509	0.00308	CcSEcCtD
Pethidine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000508	0.00307	CcSEcCtD
Pethidine—Oedema—Irinotecan—pancreatic cancer	0.000508	0.00307	CcSEcCtD
Pethidine—Pruritus—Erlotinib—pancreatic cancer	0.000504	0.00305	CcSEcCtD
Pethidine—Shock—Irinotecan—pancreatic cancer	0.0005	0.00302	CcSEcCtD
Pethidine—Oedema—Gemcitabine—pancreatic cancer	0.000495	0.00299	CcSEcCtD
Pethidine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000495	0.00299	CcSEcCtD
Pethidine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000491	0.00297	CcSEcCtD
Pethidine—Confusional state—Fluorouracil—pancreatic cancer	0.000491	0.00296	CcSEcCtD
Pethidine—Oedema—Fluorouracil—pancreatic cancer	0.000487	0.00294	CcSEcCtD
Pethidine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000487	0.00294	CcSEcCtD
Pethidine—Anorexia—Irinotecan—pancreatic cancer	0.000484	0.00293	CcSEcCtD
Pethidine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000478	0.00289	CcSEcCtD
Pethidine—Visual impairment—Docetaxel—pancreatic cancer	0.000476	0.00288	CcSEcCtD
Pethidine—Dizziness—Tamoxifen—pancreatic cancer	0.000476	0.00288	CcSEcCtD
Pethidine—Tachycardia—Fluorouracil—pancreatic cancer	0.000475	0.00287	CcSEcCtD
Pethidine—Hypotension—Irinotecan—pancreatic cancer	0.000475	0.00287	CcSEcCtD
Pethidine—Affect lability—Epirubicin—pancreatic cancer	0.000474	0.00287	CcSEcCtD
Pethidine—Anorexia—Gemcitabine—pancreatic cancer	0.000472	0.00285	CcSEcCtD
Pethidine—Dizziness—Erlotinib—pancreatic cancer	0.000471	0.00285	CcSEcCtD
Pethidine—Anorexia—Fluorouracil—pancreatic cancer	0.000464	0.0028	CcSEcCtD
Pethidine—Hypotension—Gemcitabine—pancreatic cancer	0.000462	0.00279	CcSEcCtD
Pethidine—Insomnia—Irinotecan—pancreatic cancer	0.000459	0.00278	CcSEcCtD
Pethidine—Flushing—Docetaxel—pancreatic cancer	0.000459	0.00277	CcSEcCtD
Pethidine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000458	0.00277	CcSEcCtD
Pethidine—Vomiting—Tamoxifen—pancreatic cancer	0.000458	0.00277	CcSEcCtD
Pethidine—Mood swings—Epirubicin—pancreatic cancer	0.000457	0.00276	CcSEcCtD
Pethidine—Hypotension—Fluorouracil—pancreatic cancer	0.000455	0.00275	CcSEcCtD
Pethidine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000454	0.00275	CcSEcCtD
Pethidine—Rash—Tamoxifen—pancreatic cancer	0.000454	0.00274	CcSEcCtD
Pethidine—Dermatitis—Tamoxifen—pancreatic cancer	0.000454	0.00274	CcSEcCtD
Pethidine—Vomiting—Erlotinib—pancreatic cancer	0.000453	0.00274	CcSEcCtD
Pethidine—Somnolence—Irinotecan—pancreatic cancer	0.000452	0.00273	CcSEcCtD
Pethidine—Headache—Tamoxifen—pancreatic cancer	0.000451	0.00273	CcSEcCtD
Pethidine—Rash—Erlotinib—pancreatic cancer	0.000449	0.00271	CcSEcCtD
Pethidine—Dermatitis—Erlotinib—pancreatic cancer	0.000449	0.00271	CcSEcCtD
Pethidine—Insomnia—Gemcitabine—pancreatic cancer	0.000448	0.0027	CcSEcCtD
Pethidine—Headache—Erlotinib—pancreatic cancer	0.000446	0.0027	CcSEcCtD
Pethidine—Asthenia—Sunitinib—pancreatic cancer	0.000442	0.00267	CcSEcCtD
Pethidine—Decreased appetite—Irinotecan—pancreatic cancer	0.000442	0.00267	CcSEcCtD
Pethidine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00044	0.00266	CcSEcCtD
Pethidine—Insomnia—Fluorouracil—pancreatic cancer	0.00044	0.00266	CcSEcCtD
Pethidine—Somnolence—Gemcitabine—pancreatic cancer	0.00044	0.00266	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—pancreatic cancer	0.000439	0.00265	CcSEcCtD
Pethidine—Pruritus—Sunitinib—pancreatic cancer	0.000436	0.00264	CcSEcCtD
Pethidine—Constipation—Irinotecan—pancreatic cancer	0.000434	0.00263	CcSEcCtD
Pethidine—Somnolence—Fluorouracil—pancreatic cancer	0.000433	0.00261	CcSEcCtD
Pethidine—Erythema—Docetaxel—pancreatic cancer	0.00043	0.0026	CcSEcCtD
Pethidine—Decreased appetite—Gemcitabine—pancreatic cancer	0.00043	0.0026	CcSEcCtD
Pethidine—Nausea—Tamoxifen—pancreatic cancer	0.000428	0.00258	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000424	0.00256	CcSEcCtD
Pethidine—Constipation—Gemcitabine—pancreatic cancer	0.000423	0.00256	CcSEcCtD
Pethidine—Nausea—Erlotinib—pancreatic cancer	0.000423	0.00256	CcSEcCtD
Pethidine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000423	0.00256	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—pancreatic cancer	0.000422	0.00255	CcSEcCtD
Pethidine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000419	0.00253	CcSEcCtD
Pethidine—Muscle spasms—Docetaxel—pancreatic cancer	0.000414	0.0025	CcSEcCtD
Pethidine—Dizziness—Sunitinib—pancreatic cancer	0.000408	0.00246	CcSEcCtD
Pethidine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000408	0.00246	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000407	0.00246	CcSEcCtD
Pethidine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000401	0.00242	CcSEcCtD
Pethidine—Vomiting—Sunitinib—pancreatic cancer	0.000392	0.00237	CcSEcCtD
Pethidine—Rash—Sunitinib—pancreatic cancer	0.000389	0.00235	CcSEcCtD
Pethidine—Dermatitis—Sunitinib—pancreatic cancer	0.000388	0.00235	CcSEcCtD
Pethidine—Urticaria—Fluorouracil—pancreatic cancer	0.000387	0.00234	CcSEcCtD
Pethidine—Headache—Sunitinib—pancreatic cancer	0.000386	0.00233	CcSEcCtD
Pethidine—Syncope—Docetaxel—pancreatic cancer	0.000386	0.00233	CcSEcCtD
Pethidine—Palpitations—Docetaxel—pancreatic cancer	0.00038	0.0023	CcSEcCtD
Pethidine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000378	0.00229	CcSEcCtD
Pethidine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000374	0.00226	CcSEcCtD
Pethidine—Convulsion—Docetaxel—pancreatic cancer	0.000373	0.00225	CcSEcCtD
Pethidine—Hypertension—Docetaxel—pancreatic cancer	0.000371	0.00224	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—pancreatic cancer	0.000371	0.00224	CcSEcCtD
Pethidine—Nausea—Sunitinib—pancreatic cancer	0.000366	0.00221	CcSEcCtD
Pethidine—Asthenia—Irinotecan—pancreatic cancer	0.000364	0.0022	CcSEcCtD
Pethidine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000358	0.00217	CcSEcCtD
Pethidine—Dry mouth—Docetaxel—pancreatic cancer	0.000358	0.00217	CcSEcCtD
Pethidine—Sweating—Epirubicin—pancreatic cancer	0.000356	0.00215	CcSEcCtD
Pethidine—Asthenia—Gemcitabine—pancreatic cancer	0.000355	0.00215	CcSEcCtD
Pethidine—Confusional state—Docetaxel—pancreatic cancer	0.000354	0.00214	CcSEcCtD
Pethidine—Oedema—Docetaxel—pancreatic cancer	0.000351	0.00212	CcSEcCtD
Pethidine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000351	0.00212	CcSEcCtD
Pethidine—Pruritus—Gemcitabine—pancreatic cancer	0.00035	0.00212	CcSEcCtD
Pethidine—Shock—Docetaxel—pancreatic cancer	0.000345	0.00209	CcSEcCtD
Pethidine—Pruritus—Fluorouracil—pancreatic cancer	0.000344	0.00208	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—pancreatic cancer	0.000344	0.00208	CcSEcCtD
Pethidine—Tachycardia—Docetaxel—pancreatic cancer	0.000343	0.00207	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—pancreatic cancer	0.000339	0.00205	CcSEcCtD
Pethidine—Dizziness—Irinotecan—pancreatic cancer	0.000336	0.00203	CcSEcCtD
Pethidine—Anorexia—Docetaxel—pancreatic cancer	0.000335	0.00202	CcSEcCtD
Pethidine—Sweating—Doxorubicin—pancreatic cancer	0.000329	0.00199	CcSEcCtD
Pethidine—Hypotension—Docetaxel—pancreatic cancer	0.000328	0.00198	CcSEcCtD
Pethidine—Vomiting—Irinotecan—pancreatic cancer	0.000323	0.00195	CcSEcCtD
Pethidine—Dizziness—Fluorouracil—pancreatic cancer	0.000322	0.00194	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—pancreatic cancer	0.000321	0.00194	CcSEcCtD
Pethidine—Rash—Irinotecan—pancreatic cancer	0.00032	0.00194	CcSEcCtD
Pethidine—Dermatitis—Irinotecan—pancreatic cancer	0.00032	0.00193	CcSEcCtD
Pethidine—Headache—Irinotecan—pancreatic cancer	0.000318	0.00192	CcSEcCtD
Pethidine—Insomnia—Docetaxel—pancreatic cancer	0.000318	0.00192	CcSEcCtD
Pethidine—Vomiting—Gemcitabine—pancreatic cancer	0.000315	0.0019	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—pancreatic cancer	0.000314	0.0019	CcSEcCtD
Pethidine—Somnolence—Docetaxel—pancreatic cancer	0.000312	0.00189	CcSEcCtD
Pethidine—Rash—Gemcitabine—pancreatic cancer	0.000312	0.00189	CcSEcCtD
Pethidine—Dermatitis—Gemcitabine—pancreatic cancer	0.000312	0.00188	CcSEcCtD
Pethidine—Headache—Gemcitabine—pancreatic cancer	0.00031	0.00187	CcSEcCtD
Pethidine—Flushing—Epirubicin—pancreatic cancer	0.000309	0.00187	CcSEcCtD
Pethidine—Vomiting—Fluorouracil—pancreatic cancer	0.000309	0.00187	CcSEcCtD
Pethidine—Rash—Fluorouracil—pancreatic cancer	0.000307	0.00185	CcSEcCtD
Pethidine—Dermatitis—Fluorouracil—pancreatic cancer	0.000306	0.00185	CcSEcCtD
Pethidine—Decreased appetite—Docetaxel—pancreatic cancer	0.000305	0.00184	CcSEcCtD
Pethidine—Headache—Fluorouracil—pancreatic cancer	0.000305	0.00184	CcSEcCtD
Pethidine—Nausea—Irinotecan—pancreatic cancer	0.000302	0.00182	CcSEcCtD
Pethidine—Constipation—Docetaxel—pancreatic cancer	0.0003	0.00181	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—pancreatic cancer	0.000297	0.0018	CcSEcCtD
Pethidine—Nausea—Gemcitabine—pancreatic cancer	0.000294	0.00178	CcSEcCtD
Pethidine—Erythema—Epirubicin—pancreatic cancer	0.00029	0.00175	CcSEcCtD
Pethidine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000289	0.00175	CcSEcCtD
Pethidine—Nausea—Fluorouracil—pancreatic cancer	0.000289	0.00175	CcSEcCtD
Pethidine—Flushing—Doxorubicin—pancreatic cancer	0.000286	0.00173	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—pancreatic cancer	0.000279	0.00169	CcSEcCtD
Pethidine—Erythema—Doxorubicin—pancreatic cancer	0.000269	0.00162	CcSEcCtD
Pethidine—Agitation—Epirubicin—pancreatic cancer	0.000267	0.00161	CcSEcCtD
Pethidine—Vertigo—Epirubicin—pancreatic cancer	0.000261	0.00158	CcSEcCtD
Pethidine—Syncope—Epirubicin—pancreatic cancer	0.00026	0.00157	CcSEcCtD
Pethidine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000259	0.00156	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000258	0.00156	CcSEcCtD
Pethidine—Palpitations—Epirubicin—pancreatic cancer	0.000256	0.00155	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000255	0.00154	CcSEcCtD
Pethidine—Asthenia—Docetaxel—pancreatic cancer	0.000252	0.00152	CcSEcCtD
Pethidine—Convulsion—Epirubicin—pancreatic cancer	0.000251	0.00152	CcSEcCtD
Pethidine—Hypertension—Epirubicin—pancreatic cancer	0.000251	0.00151	CcSEcCtD
Pethidine—Pruritus—Docetaxel—pancreatic cancer	0.000248	0.0015	CcSEcCtD
Pethidine—Agitation—Doxorubicin—pancreatic cancer	0.000247	0.00149	CcSEcCtD
Pethidine—Anxiety—Epirubicin—pancreatic cancer	0.000246	0.00149	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—pancreatic cancer	0.000242	0.00146	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—pancreatic cancer	0.000241	0.00146	CcSEcCtD
Pethidine—Syncope—Doxorubicin—pancreatic cancer	0.000241	0.00146	CcSEcCtD
Pethidine—Confusional state—Epirubicin—pancreatic cancer	0.000239	0.00144	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—pancreatic cancer	0.000237	0.00143	CcSEcCtD
Pethidine—Oedema—Epirubicin—pancreatic cancer	0.000237	0.00143	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000237	0.00143	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000236	0.00143	CcSEcCtD
Pethidine—Shock—Epirubicin—pancreatic cancer	0.000233	0.00141	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—pancreatic cancer	0.000233	0.00141	CcSEcCtD
Pethidine—Dizziness—Docetaxel—pancreatic cancer	0.000232	0.0014	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—pancreatic cancer	0.000232	0.0014	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—pancreatic cancer	0.000231	0.0014	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000229	0.00138	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—pancreatic cancer	0.000228	0.00138	CcSEcCtD
Pethidine—Anorexia—Epirubicin—pancreatic cancer	0.000226	0.00136	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—pancreatic cancer	0.000224	0.00135	CcSEcCtD
Pethidine—Vomiting—Docetaxel—pancreatic cancer	0.000223	0.00135	CcSEcCtD
Pethidine—Rash—Docetaxel—pancreatic cancer	0.000221	0.00134	CcSEcCtD
Pethidine—Hypotension—Epirubicin—pancreatic cancer	0.000221	0.00134	CcSEcCtD
Pethidine—Dermatitis—Docetaxel—pancreatic cancer	0.000221	0.00134	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—pancreatic cancer	0.000221	0.00134	CcSEcCtD
Pethidine—Headache—Docetaxel—pancreatic cancer	0.00022	0.00133	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000219	0.00132	CcSEcCtD
Pethidine—Oedema—Doxorubicin—pancreatic cancer	0.000219	0.00132	CcSEcCtD
Pethidine—Shock—Doxorubicin—pancreatic cancer	0.000216	0.0013	CcSEcCtD
Pethidine—Insomnia—Epirubicin—pancreatic cancer	0.000214	0.00129	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—pancreatic cancer	0.000214	0.00129	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000212	0.00128	CcSEcCtD
Pethidine—Somnolence—Epirubicin—pancreatic cancer	0.000211	0.00127	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—pancreatic cancer	0.000209	0.00126	CcSEcCtD
Pethidine—Nausea—Docetaxel—pancreatic cancer	0.000209	0.00126	CcSEcCtD
Pethidine—Decreased appetite—Epirubicin—pancreatic cancer	0.000206	0.00124	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—pancreatic cancer	0.000205	0.00124	CcSEcCtD
Pethidine—Constipation—Epirubicin—pancreatic cancer	0.000203	0.00122	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—pancreatic cancer	0.000198	0.0012	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000195	0.00118	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—pancreatic cancer	0.000195	0.00118	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000191	0.00115	CcSEcCtD
Pethidine—Urticaria—Epirubicin—pancreatic cancer	0.000188	0.00114	CcSEcCtD
Pethidine—Constipation—Doxorubicin—pancreatic cancer	0.000187	0.00113	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000181	0.00109	CcSEcCtD
Pethidine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000175	0.00105	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—pancreatic cancer	0.000174	0.00105	CcSEcCtD
Pethidine—Asthenia—Epirubicin—pancreatic cancer	0.00017	0.00103	CcSEcCtD
Pethidine—Pruritus—Epirubicin—pancreatic cancer	0.000168	0.00101	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000161	0.000976	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—pancreatic cancer	0.000157	0.00095	CcSEcCtD
Pethidine—Dizziness—Epirubicin—pancreatic cancer	0.000157	0.000947	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—pancreatic cancer	0.000155	0.000937	CcSEcCtD
Pethidine—Vomiting—Epirubicin—pancreatic cancer	0.000151	0.00091	CcSEcCtD
Pethidine—Rash—Epirubicin—pancreatic cancer	0.000149	0.000903	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—pancreatic cancer	0.000149	0.000902	CcSEcCtD
Pethidine—Headache—Epirubicin—pancreatic cancer	0.000148	0.000897	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—pancreatic cancer	0.000145	0.000876	CcSEcCtD
Pethidine—Nausea—Epirubicin—pancreatic cancer	0.000141	0.00085	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—pancreatic cancer	0.000139	0.000842	CcSEcCtD
Pethidine—Rash—Doxorubicin—pancreatic cancer	0.000138	0.000835	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—pancreatic cancer	0.000138	0.000834	CcSEcCtD
Pethidine—Headache—Doxorubicin—pancreatic cancer	0.000137	0.00083	CcSEcCtD
Pethidine—Nausea—Doxorubicin—pancreatic cancer	0.00013	0.000787	CcSEcCtD
Pethidine—OPRM1—GPCR ligand binding—CXCL8—pancreatic cancer	4.04e-05	0.000322	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCKAR—pancreatic cancer	3.97e-05	0.000317	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	3.9e-05	0.000311	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JAG2—pancreatic cancer	3.85e-05	0.000307	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TYMP—pancreatic cancer	3.81e-05	0.000304	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PRSS1—pancreatic cancer	3.8e-05	0.000303	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MEN1—pancreatic cancer	3.8e-05	0.000303	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SST—pancreatic cancer	3.72e-05	0.000296	CbGpPWpGaD
Pethidine—ALB—Metabolism—ARG2—pancreatic cancer	3.67e-05	0.000292	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.67e-05	0.000292	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JAG1—pancreatic cancer	3.64e-05	0.00029	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SHH—pancreatic cancer	3.62e-05	0.000289	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NOTCH3—pancreatic cancer	3.62e-05	0.000289	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOTCH4—pancreatic cancer	3.6e-05	0.000287	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IAPP—pancreatic cancer	3.58e-05	0.000285	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—HRAS—pancreatic cancer	3.57e-05	0.000284	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	3.5e-05	0.000278	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—HRAS—pancreatic cancer	3.48e-05	0.000277	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	3.43e-05	0.000274	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	3.43e-05	0.000274	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	3.43e-05	0.000273	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.33e-05	0.000265	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—GCG—pancreatic cancer	3.31e-05	0.000264	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ARG2—pancreatic cancer	3.3e-05	0.000263	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.22e-05	0.000257	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—HRAS—pancreatic cancer	3.22e-05	0.000256	CbGpPWpGaD
Pethidine—ALB—Metabolism—TYMP—pancreatic cancer	3.21e-05	0.000256	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	3.16e-05	0.000252	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—AKT1—pancreatic cancer	3.15e-05	0.000251	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SST—pancreatic cancer	3.14e-05	0.00025	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	3.13e-05	0.000249	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STK11—pancreatic cancer	3.11e-05	0.000248	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.1e-05	0.000247	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	3.07e-05	0.000245	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GLP1R—pancreatic cancer	3.07e-05	0.000245	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—AKT1—pancreatic cancer	3.07e-05	0.000245	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	3.06e-05	0.000244	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	3.04e-05	0.000243	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ARG2—pancreatic cancer	3.03e-05	0.000241	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—DPYD—pancreatic cancer	3.02e-05	0.000241	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PLAU—pancreatic cancer	2.95e-05	0.000235	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.93e-05	0.000233	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	2.9e-05	0.000231	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TYMP—pancreatic cancer	2.88e-05	0.000229	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	2.87e-05	0.000229	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.81e-05	0.000224	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.81e-05	0.000224	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—GCG—pancreatic cancer	2.8e-05	0.000223	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	2.79e-05	0.000223	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	2.73e-05	0.000217	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.72e-05	0.000217	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.7e-05	0.000215	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	2.67e-05	0.000213	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HES1—pancreatic cancer	2.66e-05	0.000212	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.65e-05	0.000211	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.65e-05	0.000211	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STK11—pancreatic cancer	2.63e-05	0.00021	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CG—pancreatic cancer	2.62e-05	0.000209	CbGpPWpGaD
Pethidine—ALB—Hemostasis—EGF—pancreatic cancer	2.59e-05	0.000207	CbGpPWpGaD
Pethidine—ALB—Metabolism—GLP1R—pancreatic cancer	2.59e-05	0.000206	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.55e-05	0.000203	CbGpPWpGaD
Pethidine—ALB—Metabolism—DPYD—pancreatic cancer	2.54e-05	0.000203	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.47e-05	0.000197	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	2.45e-05	0.000195	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC2A2—pancreatic cancer	2.41e-05	0.000192	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.39e-05	0.00019	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	2.38e-05	0.000189	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.38e-05	0.000189	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.37e-05	0.000189	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TERT—pancreatic cancer	2.33e-05	0.000186	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	2.32e-05	0.000185	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CD—pancreatic cancer	2.31e-05	0.000184	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.31e-05	0.000184	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	2.31e-05	0.000184	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.29e-05	0.000182	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—DPYD—pancreatic cancer	2.28e-05	0.000182	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.28e-05	0.000182	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HES1—pancreatic cancer	2.25e-05	0.000179	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	2.23e-05	0.000178	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	2.23e-05	0.000177	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CD44—pancreatic cancer	2.22e-05	0.000177	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APOE—pancreatic cancer	2.18e-05	0.000174	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	2.17e-05	0.000173	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.16e-05	0.000172	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.14e-05	0.000171	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.14e-05	0.00017	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KDR—pancreatic cancer	2.13e-05	0.00017	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GCG—pancreatic cancer	2.13e-05	0.00017	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.1e-05	0.000167	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.1e-05	0.000167	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	2.07e-05	0.000165	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.07e-05	0.000165	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	2.03e-05	0.000162	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CB—pancreatic cancer	2.01e-05	0.00016	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	2.01e-05	0.00016	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—STK11—pancreatic cancer	2e-05	0.00016	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.99e-05	0.000159	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.98e-05	0.000158	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TERT—pancreatic cancer	1.97e-05	0.000157	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	1.97e-05	0.000157	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	1.97e-05	0.000157	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGF—pancreatic cancer	1.94e-05	0.000155	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.94e-05	0.000155	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	1.89e-05	0.00015	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.89e-05	0.00015	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	1.88e-05	0.00015	CbGpPWpGaD
Pethidine—ALB—Metabolism—CD44—pancreatic cancer	1.87e-05	0.000149	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APOE—pancreatic cancer	1.84e-05	0.000147	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.83e-05	0.000146	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.81e-05	0.000145	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KDR—pancreatic cancer	1.8e-05	0.000144	CbGpPWpGaD
Pethidine—ALB—Metabolism—GCG—pancreatic cancer	1.79e-05	0.000143	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	1.79e-05	0.000143	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.73e-05	0.000138	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	1.73e-05	0.000138	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TYMS—pancreatic cancer	1.72e-05	0.000137	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	1.72e-05	0.000137	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.71e-05	0.000136	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	1.7e-05	0.000135	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	1.69e-05	0.000135	CbGpPWpGaD
Pethidine—ALB—Metabolism—STK11—pancreatic cancer	1.69e-05	0.000134	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CD44—pancreatic cancer	1.68e-05	0.000134	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	1.66e-05	0.000132	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	1.66e-05	0.000132	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.64e-05	0.000131	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGF—pancreatic cancer	1.64e-05	0.000131	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.63e-05	0.00013	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SRC—pancreatic cancer	1.61e-05	0.000128	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GCG—pancreatic cancer	1.61e-05	0.000128	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.58e-05	0.000126	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—pancreatic cancer	1.57e-05	0.000125	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.55e-05	0.000124	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NRAS—pancreatic cancer	1.55e-05	0.000124	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.54e-05	0.000123	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.51e-05	0.000121	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—STK11—pancreatic cancer	1.51e-05	0.000121	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	1.51e-05	0.00012	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.48e-05	0.000118	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.46e-05	0.000116	CbGpPWpGaD
Pethidine—ALB—Metabolism—TYMS—pancreatic cancer	1.45e-05	0.000116	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	1.45e-05	0.000115	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.45e-05	0.000115	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TGFB1—pancreatic cancer	1.44e-05	0.000115	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	1.44e-05	0.000115	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.43e-05	0.000114	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.42e-05	0.000113	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOE—pancreatic cancer	1.4e-05	0.000112	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	1.4e-05	0.000111	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.4e-05	0.000111	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.39e-05	0.000111	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	1.39e-05	0.00011	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.37e-05	0.000109	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	1.35e-05	0.000107	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	1.34e-05	0.000106	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—pancreatic cancer	1.33e-05	0.000106	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.31e-05	0.000105	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	1.31e-05	0.000104	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.3e-05	0.000104	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	1.3e-05	0.000104	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.3e-05	0.000104	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.27e-05	0.000101	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	1.27e-05	0.000101	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	1.26e-05	0.000101	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—pancreatic cancer	1.23e-05	9.77e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.22e-05	9.75e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARG—pancreatic cancer	1.22e-05	9.72e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.22e-05	9.69e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SRC—pancreatic cancer	1.21e-05	9.62e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.2e-05	9.54e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—pancreatic cancer	1.19e-05	9.45e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.18e-05	9.42e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOE—pancreatic cancer	1.18e-05	9.39e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	1.18e-05	9.37e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	1.17e-05	9.33e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	1.16e-05	9.28e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	1.16e-05	9.25e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	1.14e-05	9.08e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—pancreatic cancer	1.13e-05	9.04e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.13e-05	8.99e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.12e-05	8.89e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	1.11e-05	8.85e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	1.11e-05	8.82e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	1.1e-05	8.77e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—pancreatic cancer	1.08e-05	8.62e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	1.08e-05	8.6e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.07e-05	8.55e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CG—pancreatic cancer	1.06e-05	8.48e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOE—pancreatic cancer	1.06e-05	8.43e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	1.06e-05	8.43e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARG—pancreatic cancer	1.03e-05	8.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SRC—pancreatic cancer	1.02e-05	8.13e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CD44—pancreatic cancer	1.01e-05	8.04e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1e-05	7.98e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—pancreatic cancer	1e-05	7.98e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	1e-05	7.97e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	9.94e-06	7.92e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	9.84e-06	7.84e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	9.82e-06	7.82e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOE—pancreatic cancer	9.73e-06	7.76e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	9.69e-06	7.72e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GCG—pancreatic cancer	9.68e-06	7.71e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	9.6e-06	7.65e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	9.55e-06	7.61e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CD—pancreatic cancer	9.35e-06	7.45e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARG—pancreatic cancer	9.22e-06	7.35e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	9.18e-06	7.32e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—pancreatic cancer	9.14e-06	7.29e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	9.12e-06	7.27e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—STK11—pancreatic cancer	9.1e-06	7.25e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	8.94e-06	7.13e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—pancreatic cancer	8.89e-06	7.08e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	8.79e-06	7e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	8.5e-06	6.77e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARG—pancreatic cancer	8.48e-06	6.76e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	8.45e-06	6.73e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	8.4e-06	6.69e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—pancreatic cancer	8.37e-06	6.67e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CB—pancreatic cancer	8.15e-06	6.5e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—pancreatic cancer	8.08e-06	6.44e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.83e-06	6.24e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	7.76e-06	6.18e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	7.72e-06	6.15e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—pancreatic cancer	7.51e-06	5.98e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	7.5e-06	5.98e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	7.32e-06	5.83e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	7.25e-06	5.78e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	7.18e-06	5.72e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—pancreatic cancer	7.05e-06	5.61e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	6.73e-06	5.36e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	6.67e-06	5.31e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOE—pancreatic cancer	6.36e-06	5.07e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	6.34e-06	5.05e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—pancreatic cancer	6.32e-06	5.04e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	5.9e-06	4.7e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.82e-06	4.63e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.74e-06	4.58e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.54e-06	4.42e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.05e-06	4.02e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—pancreatic cancer	4.97e-06	3.96e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—pancreatic cancer	4.82e-06	3.84e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	4.46e-06	3.55e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.4e-06	3.51e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.36e-06	3.47e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.1e-06	3.27e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—pancreatic cancer	4.06e-06	3.24e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.8e-06	3.03e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—pancreatic cancer	3.64e-06	2.9e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.35e-06	2.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.68e-06	2.14e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.19e-06	1.75e-05	CbGpPWpGaD
